Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.

Cancer Research U.K. Epidemiology Unit, University of Oxford, Gibson Bldg., Radcliffe Infirmary, Oxford OX2 6HE, UK.
CancerSpectrum Knowledge Environment (Impact Factor: 15.16). 09/2003; 95(16):1218-26.
Source: PubMed

ABSTRACT Obesity is associated with increased breast cancer risk among postmenopausal women. We examined whether this association could be explained by the relationship of body mass index (BMI) with serum sex hormone concentrations.
We analyzed individual data from eight prospective studies of postmenopausal women. Data on BMI and prediagnostic estradiol levels were available for 624 case subjects and 1669 control subjects; data on the other sex hormones were available for fewer subjects. The relative risks (RRs) with 95% confidence intervals (CIs) of breast cancer associated with increasing BMI were estimated by conditional logistic regression on case-control sets, matched within each study for age and recruitment date, and adjusted for parity. All statistical tests were two-sided.
Breast cancer risk increased with increasing BMI (P(trend) =.002), and this increase in RR was substantially reduced by adjustment for serum estrogen concentrations. Adjusting for free estradiol reduced the RR for breast cancer associated with a 5 kg/m2 increase in BMI from 1.19 (95% CI = 1.05 to 1.34) to 1.02 (95% CI = 0.89 to 1.17). The increased risk was also substantially reduced after adjusting for other estrogens (total estradiol, non-sex hormone-binding globulin-bound estradiol, estrone, and estrone sulfate), and moderately reduced after adjusting for sex hormone-binding globulin, whereas adjustment for the androgens (androstenedione, dehydroepiandrosterone, dehydroepiandrosterone sulfate, and testosterone) had little effect on the excess risk.
The results are compatible with the hypothesis that the increase in breast cancer risk with increasing BMI among postmenopausal women is largely the result of the associated increase in estrogens, particularly bioavailable estradiol.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast cancer is an increasing public health problem. Substantial advances have been made in the treatment of breast cancer, but the introduction of methods to predict women at elevated risk and prevent the disease has been less successful. Here, we summarize recent data on newer approaches to risk prediction, available approaches to prevention, how new approaches may be made, and the difficult problem of using what we already know to prevent breast cancer in populations. During 2012, the Breast Cancer Campaign facilitated a series of workshops, each covering a specialty area of breast cancer to identify gaps in our knowledge. The risk-and-prevention panel involved in this exercise was asked to expand and update its report and review recent relevant peer-reviewed literature. The enlarged position paper presented here highlights the key gaps in risk-and-prevention research that were identified, together with recommendations for action. The panel estimated from the relevant literature that potentially 50% of breast cancer could be prevented in the subgroup of women at high and moderate risk of breast cancer by using current chemoprevention (tamoxifen, raloxifene, exemestane, and anastrozole) and that, in all women, lifestyle measures, including weight control, exercise, and moderating alcohol intake, could reduce breast cancer risk by about 30%. Risk may be estimated by standard models potentially with the addition of, for example, mammographic density and appropriate single-nucleotide polymorphisms. This review expands on four areas: (a) the prediction of breast cancer risk, (b) the evidence for the effectiveness of preventive therapy and lifestyle approaches to prevention, (c) how understanding the biology of the breast may lead to new targets for prevention, and (d) a summary of published guidelines for preventive approaches and measures required for their implementation. We hope that efforts to fill these and other gaps will lead to considerable advances in our efforts to predict risk and prevent breast cancer over the next 10 years.
    Breast cancer research: BCR 09/2014; 16(5):446. DOI:10.1186/s13058-014-0446-2 · 5.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to examine whether different types of posts differentially affect participant engagement and if engagement with social media enhances weight loss. Data are a subanalysis from a randomized weight loss study with a 4-month follow-up support period via private Facebook groups and monthly meetings. Counselors posted five different post types/week based on social cognitive theory (weight-related, recipes, nutrition information, poll votes, or requests for suggestions). Types of participant engagement (likes, comments/poll votes, and views) were assessed. Poll votes were the most engaging (mean number of votes or comments/poll 14.6 ± 3.4, P < 0.01) followed by suggestions (9.1 ± 2.7 posts, P < 0.01) and weight-related posts (7.4 ± 3.1 posts, P < 0.01). Engagement with Facebook was significantly associated with weight loss during the 4-month maintenance period (B = -0.09, P = 0.04). The findings provide evidence for ways to provide social support during weight loss interventions using remote methodology.
    12/2014; 4(4):355-62. DOI:10.1007/s13142-014-0274-z
  • Source
    01/2013; 3(3):698-709. DOI:10.9734/BJMMR/2013/2816